Nonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimer

References

• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2006). Cancer statistics, 2006. Cancer J Clin, 56:106–30.
   PubMed Web of Science ®Google Scholar
• DiSaia PJ, Bloss JD. (2003). Treatment of ovarian cancer: New strategies. Gynecol Oncol, 90:S24–32.
   PubMed Web of Science ®Google Scholar
• Bartlett JM, Langdon SP, Simpson BJ. (1996). The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer, 73:301–6.
   PubMed Web of Science ®Google Scholar
• Nicholson RI, Gee JM, Harper ME. (2001). EGFR and cancer prognosis. Eur J Cancer, 37(Suppl. 4):S9–15.
   PubMed Web of Science ®Google Scholar
• Ranson M. (2002). ZD1839 (Iressa): For more than just non-small cell lung cancer. Oncologist, 7(Suppl. 4):16–24.
   PubMedGoogle Scholar
• Raymond E, Faivre S, Armand JP. (2000). Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs, 60(Suppl. 1):15–23.
   PubMed Web of Science ®Google Scholar
• Alper O, Bergmann-Leitner ES, Bennett TA, Hacker NF, Stromberg K, Stetler-Stevenson WG. (2001). Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. J Natl Cancer Inst, 93:1375–84.
   PubMed Web of Science ®Google Scholar
• Thomas M, Ge Q, Lu JJ, Chen J, Klibanov AM. (2005). Cross-linked small polyethylenimines: While still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res, 22:373–80.
   PubMed Web of Science ®Google Scholar
• Li S, Huang L. (2000). Nonviral gene therapy: Promises and challenges. Gene Ther, 7:31–4.
   PubMed Web of Science ®Google Scholar
• Huang L, Li S. (1997). Liposomal gene delivery: A complex package. Nat Biotechnol, 15:620–1.
   PubMed Web of Science ®Google Scholar
• Schatzlein AG. (2001). Non-viral vectors in cancer gene therapy: Principles and progress. Anticancer Drug, 2:275–304.
   Google Scholar
• Lollo CP, Banaszczyk MG, Chiou HC. (2000). Obstacles and advances in non-viral gene delivery. Curr Opin Mol Ther, 2:136–42.
   PubMed Web of Science ®Google Scholar
• Malhotra M, Kulamarva A, Sebak S, Paul A, Bhathena J, Mirzaei M, . (2009). Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells. Drug Dev Ind Pharm, 35:719–26.
   PubMed Web of Science ®Google Scholar
• Pouton CW, Seymour LW. (2001). Key issues in non-viral gene delivery. Adv Drug Deliv Rev, 46:187–203.
   PubMed Web of Science ®Google Scholar
• Schmidt-Wolf GD, Schmidt-Wolf IG. (2003). Non-viral and hybrid vectors in human gene therapy: An update. Trends Mol Med, 9:67–72.
   PubMed Web of Science ®Google Scholar
• Heansler J, Szoka FC. (1997). A CD2/CD28 chimeric receptor triggers the CD28 signaling pathway in CTLL.2 cells. Gene Ther, 4:823–32.
   PubMed Web of Science ®Google Scholar
• Choi JS, Nam K, Park J, Kim JB, Lee JK, Park J. (2004). Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release, 99:445–56.
   PubMed Web of Science ®Google Scholar
• Kim JB, Choi JS, Nam K, Lee M, Park JS, Lee JK. (2006). Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg. J Control Release, 10:110–7.
   Web of Science ®Google Scholar
• Boado RJ, Pardridge WM. (1998). Ten nucleotide cis element in the 3'-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Mol Brain Res, 59:109–13.
   PubMedGoogle Scholar
• Zhang Y, Lee HJ, Boado RJ, Pardridge WM. (2002). Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med, 4:183–94.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, . (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst, 82:1107–12.
   PubMed Web of Science ®Google Scholar
• Favaro E, Indraccolo S. (2007). Gene therapy of cancer in the clinic: Good news in sight from Asia? Curr Opin Mol Ther, 9:477–82.
   PubMed Web of Science ®Google Scholar
• Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, . (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci U S A, 92:7297–301.
   PubMed Web of Science ®Google Scholar
• Kichler A. (2004). Gene transfer with modified polyethylenimines. J Gene Med, 6:S3–10.
   PubMed Web of Science ®Google Scholar
• Ohana P, Bibi O, Matouk I, Levy C, Birman T, Ariel I, . (2002). Use of H19 regulatory sequences for targeted gene therapy in cancer. Int J Cancer, 98:645–50.
   PubMed Web of Science ®Google Scholar
• Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. (1999). PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther, 6:595–605.
   PubMed Web of Science ®Google Scholar
• Zhong H, He ZG, Li Z, Li GY, Shen SR, Li XL. (2008). Studies on polyamidoamine dendrimers as efficient gene delivery vector. J Biomater Appl, 22:527–44.
   PubMed Web of Science ®Google Scholar
• Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. (2003). In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 24:1121–34.
   PubMed Web of Science ®Google Scholar
• Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. (2003). The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm, 252:263–6.
   PubMed Web of Science ®Google Scholar